| Bioactivity | HIV-1 protease-IN-12 (compound 35b) is a HIV-1 protease inhibitor with an IC50 of 0.51 nM. HIV-1 protease-IN-12 also inhibits drug-resistant variant[1]. |
| Name | HIV-1 protease-IN-12 |
| CAS | 2925287-59-6 |
| Formula | C25H35N3O5S |
| Molar Mass | 489.63 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Huiyu Zhou, et al. Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant. Eur J Med Chem. 2023 Jul 5;255:115389. |
HIV-1 protease-IN-12
CAS: 2925287-59-6 F: C25H35N3O5S W: 489.63
HIV-1 protease-IN-12 (compound 35b) is a HIV-1 protease inhibitor with an IC50 of 0.51 nM. HIV-1 protease-IN-12 also inh
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.